Clinically, no protein expression or gene profiles are used to aid prognosis, despite the various immunohistochemical markers used in other cancers, such as breast cancer where oestrogen and progesterone receptors are used to inform on disease coarse and management. This evidence concerns the gene PGR and breast carcinoma.